Process Development for Cell Therapies 2023 Hilton Boston Back Bay, Boston

Welcome to the 2nd Process Development for Cell Therapies Summit: Driving Process Automation, Affordability and Scalability for Global Cell Therapies

Join 80+ experts from BMS, Janssen, ArsenalBio, Bluebird Bio, Notch Therapeutics, Bayer, and more, looking to streamline cell therapy process development by sharing best practices and pre-competitive learnings to supercharge your pipeline development.

This is your opportunity to engage with the process development for the cell therapy industry, gain insights into best practices, and progress in a pre-competitive space.

. REVIEW The Challenges, Roles and Emerging Trends in Process Development for Cell Therapies with Janssen, 2Seventy Bio and Immatics Biotechnology
. INNOVATE analytical methods and digital platforms to ensure product quality and efficacy with Arsenal Bio and Caribou Biosciences
. OPTIMIZE scalability in an automated approach to reduce human error throughout phase development with Bayer and Glycostem Therapeutics
. MINIMIZE the time of process while maximizing quality of yield with Bristol Myers Squibb and Carisma Therapeutics
. EXAMINE the technical advancements required to drive process development forward in both upstream and downstream processes with Notch Therapeutics and Tmunity Therapeutics

Join us June 20-22, 2023 in Boston, MA!

Speakers: Adan Rodriguez Arizpe Senior Scientist Process Development Technology Bristol Myers Squibb, Aleks Guvenel Associate Director – Process Development Quell Therapeutics, Andrew Snowden Senior Directo – Allogeneic and Autologous Cell Therapy Development Janssen Global Services, LLC, Carlos Marti-Figueroa Cellular Process Development Scientist bluebird bio, Chloe Hurling Manager, Non-Clinical Cell Manufacturing Notch Therapeutics, Eileen Yoshida Process Development Scientist Notch Therapeutics, Farhatullah Syed Group Leader and Senior Scientist King Faisal Specialist Hospital and Research, Isaac Zentner Associate Director, Process Development CARISMA Therapeutics Inc., Jenessa Smith Director – Process Development Arsenal Biosciences, John Veluchamy Head of Cell Therapy and Process Development Glycostem, Julia Sable Director – Chemistry, Manufacturing, Controls and Project Management Tmunity Therapeutics Inc., Malavosklish (Liz) Bikram-Liles Associate Director – Process Development and Cell Therapy Carisma Therapeutics, Mamta Kalra Senior Director – Chemistry Manufacturing and Controls Immatics Biotechnologies, Mariam Ammari Technical Director, SCT and GMP Labs MD Anderson Cancer Center, Maxim Sidorov Senior Process Development Engineer Caribou Biosciences, Sheetal Rao Associate Director Quality and Regulatory MD Anderson Cancer Center, Yan Wang Director and Head of Cellular Process Development 2SeventyBio, Yuechen Zhu Process Development Scientist Bayer